Subretinal recombinant tissue plasminogen activator injection and pneumatic displacement of thick submacular hemorrhage in Age-Related macular degeneration. - Wikidata - wikimedia - TriplyDB

Subretinal recombinant tissue plasminogen activator injection and pneumatic displacement of thick submacular hemorrhage in Age-Related macular degeneration.

Subretinal recombinant tissue plasminogen activator injection and pneumatic displacement of thick submacular hemorrhage in Age-Related macular degeneration.

http://www.wikidata.org/entity/Q44921571

about

An arched micro-injector (ARCMI) for innocuous subretinal injection Transconjunctival sutureless vitrectomy with tissue plasminogen activator, gas and intravitreal bevacizumab in the management of predominantly hemorrhagic age-related macular degeneration.Tissue plasminogen activator-assisted vitrectomy for submacular hemorrhage due to age-related macular degeneration Displacement of submacular hemorrhage associated with age-related macular degeneration using vitrectomy and submacular tPA injection followed by intravitreal ranibizumab Surgery for hemorrhagic choroidal neovascular lesions of age-related macular degeneration: ophthalmic findings: SST report no. 13.Recombinant tissue plasminogen activator, vitrectomy, and gas for recent submacular hemorrhage displacement due to retinal macroaneurysm.Vitrectomy for the treatment of submacular hemorrhages from macular degeneration: a comparison of submacular hemorrhage/membrane removal and submacular tissue plasminogen activator-assisted pneumatic displacement.Clinical characteristics and current treatment of age-related macular degeneration.Intrasurgical assessment of subretinal tPA injection for submacular hemorrhage in the PIONEER study utilizing intraoperative OCT.Management of subretinal macular haemorrhage by direct administration of tissue plasminogen activator.Optical Coherence Tomographic Features and Prognosis of Pneumatic Displacement for Submacular Hemorrhage.Vitrectomy with subretinal tissue plasminogen activator and ranibizumab for submacular haemorrhages secondary to age-related macular degeneration: retrospective case series of 45 consecutive cases Retinal safety of intravitreal rtPA in healthy rats and under excitotoxic conditions.Surgical treatment of age-related macular degeneration.Treatment for submacular hemorrhage associated with neovascular age-related macular degeneration.Literature review of recombinant tissue plasminogen activator used for recent-onset submacular hemorrhage displacement in age-related macular degeneration.Radiating hemorrhage in exudative age-related macular degeneration.A New Method of Subretinal Injection of Tissue Plasminogen Activator and Air in Patients With Submacular Hemorrhage.Surgically Induced Focal Retinal Detachment Does Not Cause Detectable SD-OCT Retinal Changes in Normal Human Retina Subretinal recombinant tissue plasminogen activator and pneumatic displacement for the management of subretinal hemorrhage occurring after anti-VEGF injections for wet AMD.Valsalva-Related Subretinal Hemorrhage as a Presenting Symptom of Polypoidal Choroidal Vasculopathy.Intravitreal recombinant tissue plasminogen activator without and with additional gas injection in patients with submacular haemorrhage associated with age-related macular degeneration.Massive subretinal and subretinal pigment epithelial hemorrhage displacement with perfluorocarbon liquid using a two-step vitrectomy technique.Compatibility of recombinant tissue plasminogen activator (rtPA) and aflibercept or ranibizumab coapplied for neovascular age-related macular degeneration with submacular haemorrhage.Polypoidal Choroidal Vasculopathy.

P2860

Q28541782-F21518D9-191A-4647-9779-4967A1E041F7 Q33682143-923DFC36-B28F-48FC-BA39-14D4CCFA1C90 Q33900503-2117D996-4661-472A-8085-8E96609CF8D1 Q34019693-4C6E9F5A-39AE-4E82-BD54-9B859383E24D Q34081858-23468C50-4D19-43AC-AD94-724FB8C2D8B3 Q34366841-0299867A-2D21-4AF1-BAF5-9F147349DE2F Q34565343-472CB520-1026-41B7-AE48-D755E2E988E5 Q34930298-7B0C9635-7850-4B1E-9DD4-B9B6DDC3B489 Q35598415-4AE8C6EF-A47A-4D8A-81E5-750D1243CE2F Q35761653-93798D51-37D2-4556-8DC4-0F5F8C0C5D23 Q36228351-CB4C8C4E-86FB-4751-BD5D-CE7A4CF5B4D6 Q37085388-32D65A78-2777-43D4-B38B-1704083DA86F Q37412847-7AB1C47E-299F-4BA4-90E0-B2DF56324519 Q37879175-BCD13586-B892-4531-BF28-21EE564997F2 Q37951624-ADBA718D-0137-4E0F-ADD9-AD10649D38E5 Q38052994-9575A3F4-98BD-4008-A7BA-07A72A162D40 Q40525714-2080BD99-ADC0-4068-8100-88341D4516B4 Q41322369-3F5ABAFF-2287-4093-A414-52F07C770CB4 Q42379453-3DD2BCAB-2B2A-4120-957D-213D5993938A Q42729433-85A61E40-4DFC-462C-A1CB-DEE9319523E0 Q43375862-AFB35820-9622-45CE-92E3-179BE552772C Q44642952-EE62160E-D0B3-4578-AF2F-77E65609CF28 Q52880725-61AAAB0E-B8F9-4000-8BAA-B2D2F9804E28 Q54286581-BA567E92-AB7C-4A23-89A9-8B7E0580C8D4 Q55714679-2C744506-2EF4-42EC-8C89-3ED34CD251CF

P2860

Subretinal recombinant tissue plasminogen activator injection and pneumatic displacement of thick submacular hemorrhage in Age-Related macular degeneration.

http://www.wikidata.org/entity/Q44921571

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年学术文章

@wuu

2004年学术文章

@zh-cn

2004年学术文章

@zh-hans

2004年学术文章

@zh-my

2004年学术文章

@zh-sg

2004年學術文章

@yue

2004年學術文章

@zh

2004年學術文章

@zh-hant

name

Subretinal recombinant tissue ...... -Related macular degeneration.

@en

Subretinal recombinant tissue ...... -Related macular degeneration.

@nl

type

label

Subretinal recombinant tissue ...... -Related macular degeneration.

@en

Subretinal recombinant tissue ...... -Related macular degeneration.

@nl

prefLabel

Subretinal recombinant tissue ...... -Related macular degeneration.

@en

Subretinal recombinant tissue ...... -Related macular degeneration.

@nl

P1433

Q44921571-67AFAC3A-4529-435C-8D23-41327653CE63

P1476

Q44921571-5E95F363-41D3-4232-8876-2579D7F47282

P2093

Q44921571-0464266F-A04E-463B-AC2D-F8EDC04557B4

Q44921571-2EE36505-935F-48FF-9A37-EF65E319CD7D

Q44921571-64D4DD16-49E3-40AB-926C-57CF053B5699

Q44921571-74CB478D-E048-4FC5-8E9F-BA746A1897DC

Q44921571-C15786BB-BBE4-4C68-A8A6-77C21A1BEA54

P304

Q44921571-D0161859-6634-4D64-9A3E-0B08F9580A14

P31

Q44921571-6CE4B52A-2F55-4AD4-8FBC-9191F24366FA

P356

Q44921571-AC76670B-29F2-4740-8459-EDDEAD1C4367

P433

Q44921571-676F829A-10D2-4931-85C4-BB0E1BB169D9

P478

Q44921571-4B355A59-7695-4DE5-86D9-F4D4A12465CC

P577

Q44921571-B5BCC922-461F-4FE7-89B5-B686A8E98C6A

P698

Q44921571-F8915156-16C6-4CD9-ACF8-A3E5DB4ADD06

P356

J.OPHTHA.2003.10.020

P1433

P1476

Subretinal recombinant tissue ...... -Related macular degeneration.

@en

P2093

Carl C Awh

http://www.w3.org/2001/XMLSchema#string

David R Chow

http://www.w3.org/2001/XMLSchema#string

Kirk H Packo

http://www.w3.org/2001/XMLSchema#string

Mathew W MacCumber

http://www.w3.org/2001/XMLSchema#string

Sébastien Olivier

http://www.w3.org/2001/XMLSchema#string

P304

1201-1208

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.OPHTHA.2003.10.020

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

111

http://www.w3.org/2001/XMLSchema#string

P577

2004-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15177972

http://www.w3.org/2001/XMLSchema#string